Physician profile
Gregory R Cramer
NPI 1700469814
$759.23
in general payments reported to CMS, 2019-2025
11 companies · $640 in 2025
The $640 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $106 · 2024: $13.28 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $254.28 | 2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $107.53 | 2025 | |
| Vapotherm INC | $105.89 | 2023 | Vapotherm |
| Novartis Pharmaceuticals Corporation | $73.34 | 2025 | |
| Alexion Pharmaceuticals, INC. | $58.86 | 2025 | Ultomiris |
| Gilead Sciences, INC. | $51.99 | 2025 | Trodelvy |
| Pfizer INC. | $32.34 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $22.70 | 2025 | Enhertu |
| Agios Pharmaceuticals, INC. | $21.01 | 2025 | Pyrukynd |
| Eisai INC. | $16.39 | 2025 | |
| Pharmacosmos Therapeutics INC. | $14.90 | 2025 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.